Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioRestorative Therapies, Inc.

1.80
+0.04002.27%
Volume:3.58K
Turnover:6.40K
Market Cap:13.51M
PE:-1.56
High:1.80
Open:1.79
Low:1.78
Close:1.76
Loading ...
Apr 03, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 30, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2024

Major Issues Report

Form 8-K - Current report
Mar 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Major Issues Report

Form 8-K - Current report
Feb 05, 2024

Major Issues Report

Form 8-K - Current report
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 16, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 13, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2023

Major Issues Report

8-K - Current report
Apr 06, 2023

Major Issues Report

8-K - Current report
Mar 28, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 27, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]